Log in or Sign up for Free to view tailored content for your specialty!
Liver Injury/Regeneration News
Machine learning models strong predictors of short-term survival in ACLF patients after LT
Machine learning models, compared with traditional models, demonstrated good performance in the prediction of short-term prognosis following liver transplant in patients with acute-on-chronic liver failure, according to research.
Most liver transplant recipients mount adequate COVID-19 antibody response
The majority of liver transplant recipients are able to produce a functional antibody response to COVID-19 infection, according to data published in Gut.
Log in or Sign up for Free to view tailored content for your specialty!
Hepatology top 10 from 2021: NAFLD management, guideline updates, NASH treatment
Healio presents the following report on the top 10 hepatology peer-tested articles from 2021.
Family history of diabetes may increase risk for NAFLD
People with a parent, sibling or child with diabetes have increased risk for developing nonalcoholic fatty liver disease, or NAFLD, regardless of their own glucose status, according to study findings.
With rising HBV burden, experts say it is critical to implement new vaccine guideline
The CDC’s Advisory Committee on Immunization Practices recently issued a universal recommendation that all adults aged 19 to 59 years receive the hepatitis B vaccine.
Cholestatic pattern common in NAFLD, raises risk for adverse liver events
Patients with nonalcoholic fatty liver disease and liver-involved fibrosis frequently had a cholestatic pattern that increased the risk for liver-related events, according to a presentation at The Liver Meeting Digital Experience.
Virtual specialist experience linked to better survival in PCP-treated liver disease
When primary care physicians interact with virtual specialists in hepatology, more of their patients have improved survival rate beyond the initial consultation, according to a presenter at The Liver Meeting Digital Experience.
10 recent reports from The Liver Meeting Digital Experience
Healio Gastroenterology and Hepatology presents the following report on highlights from The Liver Meeting Digital Experience.
Pegbelfermin improves markers of fibrosis in NASH
Pegbelfermin was safe and effective in improving markers of steatosis, fibrosis and inflammation among patients with nonalcoholic steatohepatitis with stage 3 fibrosis, according to a presentation at The Liver Meeting Digital Experience.
Increased fatty liver disease awareness needed to mitigate burden among young adults
Increased awareness is needed to mitigate burden fatty liver disease and modifiable risk factors among adolescents and young adults, according to research presented at The Liver Meeting Digital Experience.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read